Found: 71
Select item for more details and to access through your institution.
Erratum to: Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 11, p. 1694, doi. 10.1093/jjco/hyab156
- By:
- Publication type:
- Article
Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 6, p. 911, doi. 10.1093/jjco/hyab029
- By:
- Publication type:
- Article
Phase 1 study of ombrabulin in combination with cisplatin (CDDP) in Japanese patients with advanced solid tumors.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 11, p. 1000, doi. 10.1093/jjco/hyw122
- By:
- Publication type:
- Article
A short interval between bevacizumab and anti-epithelial growth factor receptor therapy interferes with efficacy of subsequent anti-EGFR therapy for refractory colorectal cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 3, p. 228, doi. 10.1093/jjco/hyv193
- By:
- Publication type:
- Article
A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 2, p. 460, doi. 10.1245/s10434-019-07654-8
- By:
- Publication type:
- Article
A phase II trial of prophylactic olanzapine combined with palonosetron and dexamethasone for preventing nausea and vomiting induced by cisplatin.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2016, v. 12, n. 3, p. 254, doi. 10.1111/ajco.12489
- By:
- Publication type:
- Article
Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 740, doi. 10.1007/s10637-014-0154-x
- By:
- Publication type:
- Article
A triplet combination of FOLFOXIRI plus cetuximab as first-line treatment in RAS wild-type, metastatic colorectal cancer: a dose-escalation phase Ib study.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 4, p. 701, doi. 10.1007/s10147-020-01842-3
- By:
- Publication type:
- Article
Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis.
- Published in:
- International Journal of Clinical Oncology, 2016, v. 21, n. 5, p. 890, doi. 10.1007/s10147-016-0963-3
- By:
- Publication type:
- Article
Differences in attitude toward adjuvant chemotherapy between colorectal cancer survivors and the medical staff of Japanese hospitals.
- Published in:
- International Journal of Clinical Oncology, 2015, v. 20, n. 4, p. 755, doi. 10.1007/s10147-014-0772-5
- By:
- Publication type:
- Article
Long-term outcomes and prognostic factors of patients with advanced gastric cancer treated with S-1 plus cisplatin combination chemotherapy as a first-line treatment.
- Published in:
- International Journal of Clinical Oncology, 2014, v. 19, n. 4, p. 656, doi. 10.1007/s10147-013-0610-1
- By:
- Publication type:
- Article
A retrospective comparison of S-1 plus cisplatin and capecitabine plus cisplatin for patients with advanced or recurrent gastric cancer.
- Published in:
- International Journal of Clinical Oncology, 2013, v. 18, n. 3, p. 539, doi. 10.1007/s10147-012-0416-6
- By:
- Publication type:
- Article
A case of heavily pretreated rectal cancer with disseminated intravascular coagulation that improved following reintroduction of FOLFOX plus bevacizumab.
- Published in:
- International Journal of Clinical Oncology, 2011, v. 16, n. 6, p. 766, doi. 10.1007/s10147-011-0242-2
- By:
- Publication type:
- Article
Retrospective analysis of cetuximab monotherapy for patients with irinotecan-intolerant metastatic colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2011, v. 16, n. 4, p. 416, doi. 10.1007/s10147-011-0216-4
- By:
- Publication type:
- Article
Phase I/II study of irinotecan, 5-fluorouracil, andl-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2004, v. 9, n. 5, p. 364, doi. 10.1007/s10147-004-0407-3
- By:
- Publication type:
- Article
Phase I study of irinotecan and S-1 combination therapy in patients with metastatic gastric cancer.
- Published in:
- International Journal of Clinical Oncology, 2003, v. 8, n. 6, p. 374, doi. 10.1007/s10147-003-0359-z
- By:
- Publication type:
- Article
Progression-free survival and time to progression as surrogate markers of overall survival in patients with advanced gastric cancer: analysis of 36 randomized trials.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 3, p. 1224, doi. 10.1007/s10637-011-9648-y
- By:
- Publication type:
- Article
Phase II study of combination chemotherapy with irinotecan and cetuximab for pretreated metastatic colorectal cancer harboring wild-type KRAS.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 4, p. 688, doi. 10.1007/s10637-009-9382-x
- By:
- Publication type:
- Article
The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835918820298
- By:
- Publication type:
- Article
The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835918820298
- By:
- Publication type:
- Article
A prospective survey of comprehensive score for financial toxicity in Japanese cancer patients: report on a pilot study.
- Published in:
- Ecancermedicalscience, 2018, v. 12, n. 844-874, p. 1, doi. 10.3332/ecancer.2018.847
- By:
- Publication type:
- Article
A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as First-line Therapy for Japanese Advanced/Recurrent Colorectal Cancer Patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2013, v. 43, n. 11, p. 1080, doi. 10.1093/jjco/hyt127
- By:
- Publication type:
- Article
Phase II Study of Concurrent Chemoradiotherapy at the Dose of 50.4 Gy with Elective Nodal Irradiation for Stage II–III Esophageal Carcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2013, v. 43, n. 6, p. 608, doi. 10.1093/jjco/hyt048
- By:
- Publication type:
- Article
Lapatinib Plus Trastuzumab for a Patient with Heavily Pre-treated Gastric Cancer that Progressed after Trastuzumab.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 5, p. 663, doi. 10.1093/jjco/hyr014
- By:
- Publication type:
- Article
Randomized Phase II Study Comparing Dose Escalated Weekly Paclitaxel vs. Standard Dose Weekly Paclitaxel for Patients with Previously Treated Advanced Gastric Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 2, p. 287, doi. 10.1093/jjco/hyq206
- By:
- Publication type:
- Article
Phase II Study of Combination Chemotherapy with Biweekly Cetuximab and Irinotecan for Pre-treated Metastatic Colorectal Cancer Harboring Wild-type KRAS.
- Published in:
- Japanese Journal of Clinical Oncology, 2010, v. 40, n. 7, p. 699, doi. 10.1093/jjco/hyq026
- By:
- Publication type:
- Article
Case Series of Cetuximab Monotherapy for Patients with Pre-treated Colorectal Cancer Complicated with Hyperbilirubinemia due to Severe Liver Metastasis.
- Published in:
- Japanese Journal of Clinical Oncology, 2010, v. 40, n. 3, p. 275, doi. 10.1093/jjco/hyp161
- By:
- Publication type:
- Article
A Phase I Trial of 5-Fluorouracil with Cisplatin and Concurrent Standard-dose Radiotherapy in Japanese Patients with Stage II/III Esophageal Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2009, v. 39, n. 1, p. 37
- By:
- Publication type:
- Article
Chemotherapy for Gastric Cancer that Recurs After Adjuvant Chemotherapy with S-1.
- Published in:
- Japanese Journal of Clinical Oncology, 2008, v. 38, n. 11, p. 786, doi. 10.1093/jjco/hyn096
- By:
- Publication type:
- Article
Central Venous Access Port-related Complications in Outpatient Chemotherapy for Colorectal Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2007, v. 37, n. 12, p. 951, doi. 10.1093/jjco/hym118
- By:
- Publication type:
- Article
Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Neutropenia as a Predictive Factor in Metastatic Colorectal Cancer Treated With TAS-102.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Depth of response predicts the clinical outcome of advanced HER2-positive gastric cancer to trastuzumab-based first-line chemotherapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Impact of docetaxel in addition to cisplatin and fluorouracil as neoadjuvant treatment for resectable stage III or T3 esophageal cancer: a propensity score-matched analysis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 2, p. 357, doi. 10.1007/s00280-015-2806-8
- By:
- Publication type:
- Article
CA19-9 level as a prognostic and predictive factor of bevacizumab efficacy in metastatic colorectal cancer patients undergoing oxaliplatin-based chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 2, p. 409, doi. 10.1007/s00280-013-2367-7
- By:
- Publication type:
- Article
Phase 1 pharmacokinetic study of MK-0646 (dalotuzumab), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in combination with cetuximab and irinotecan in Japanese patients with advanced colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 643, doi. 10.1007/s00280-013-2240-8
- By:
- Publication type:
- Article
Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 301, doi. 10.1007/s00280-010-1487-6
- By:
- Publication type:
- Article
PS02.162: THREE-YEAR OVERALL SURVIVAL UPDATE FROM PHASE II STUDY OF CHEMOSELECTION WITH DCF AND SUBSEQUENT CONVERSION SURGERY FOR LOCALLY ADVANCED UNRESECTABLE ESOPHAGEAL CANCER.
- Published in:
- Diseases of the Esophagus, 2018, v. 31, n. 13, p. 167, doi. 10.1093/dote/doy089.PS02.162
- By:
- Publication type:
- Article
Cetuximab plus FOLFOX for Patients with Metastatic Colorectal Cancer with Poor Performance Status and/or Severe Tumor-Related Complications.
- Published in:
- Case Reports in Oncology, 2010, v. 3, n. 2, p. 282, doi. 10.1159/000319474
- By:
- Publication type:
- Article
Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 6, p. 1050, doi. 10.1007/s10120-018-0825-y
- By:
- Publication type:
- Article
Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer.
- Published in:
- Gastric Cancer, 2015, v. 18, n. 4, p. 824, doi. 10.1007/s10120-014-0420-9
- By:
- Publication type:
- Article
Prognosis of patients with advanced gastric cancer by HER2 status and trastuzumab treatment.
- Published in:
- Gastric Cancer, 2013, v. 16, n. 2, p. 261, doi. 10.1007/s10120-012-0179-9
- By:
- Publication type:
- Article
Fluoropyrimidine plus cisplatin for patients with advanced or recurrent gastric cancer with peritoneal metastasis.
- Published in:
- Gastric Cancer, 2013, v. 16, n. 1, p. 48, doi. 10.1007/s10120-012-0143-8
- By:
- Publication type:
- Article
Reporting patient characteristics and stratification factors in randomized trials of systemic chemotherapy for advanced gastric cancer.
- Published in:
- Gastric Cancer, 2012, v. 15, n. 2, p. 137, doi. 10.1007/s10120-011-0083-8
- By:
- Publication type:
- Article
Association of fluoropyrimidines, platinum agents, taxanes, and irinotecan in any line of chemotherapy with survival in patients with advanced gastric cancer.
- Published in:
- Gastric Cancer, 2011, v. 14, n. 2, p. 155, doi. 10.1007/s10120-011-0019-3
- By:
- Publication type:
- Article
Retrospective analysis of clinical results and predictors of response in chemo-naïve patients with advanced gastric cancer treated with S-1, an oral fluoropyrimidine derivative, as single-agent chemotherapy.
- Published in:
- Gastric Cancer, 2004, v. 7, n. 4, p. 204, doi. 10.1007/s10120-004-0294-3
- By:
- Publication type:
- Article
Efficacy of palliative radiotherapy for gastric bleeding in patients with unresectable advanced gastric cancer: a retrospective cohort study.
- Published in:
- BMC Palliative Care, 2015, v. 14, n. 1, p. 1, doi. 10.1186/s12904-015-0034-y
- By:
- Publication type:
- Article
Genetic polymorphisms of FCGR2A encoding Fcγ receptor IIa in a Japanese population and functional analysis of the L273P variant.
- Published in:
- Immunogenetics, 2012, v. 64, n. 12, p. 869, doi. 10.1007/s00251-012-0646-9
- By:
- Publication type:
- Article
Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer.
- Published in:
- Oncology, 2017, v. 93, n. 5, p. 329, doi. 10.1159/000479280
- By:
- Publication type:
- Article